InvestorsObserver
×
News Home

Should Biotechnology Stock Viking Therapeutics Inc (VKTX) Be in Your Portfolio Tuesday?

Tuesday, March 21, 2023 12:03 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Viking Therapeutics Inc (VKTX) Be in Your Portfolio Tuesday?

Viking Therapeutics Inc (VKTX) is near the top in its industry group according to InvestorsObserver. VKTX gets an overall rating of 80. That means it scores higher than 80 percent of stocks. Viking Therapeutics Inc gets a 93 rank in the Biotechnology industry. Biotechnology is number 35 out of 148 industries.

Overall Score - 80
VKTX has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on VKTX!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 80 would rank higher than 80 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Viking Therapeutics Inc Stock Today?

Viking Therapeutics Inc (VKTX) stock has fallen -12.35% while the S&P 500 has risen 0.63% as of 11:53 AM on Tuesday, Mar 21. VKTX is lower by -$1.44 from the previous closing price of $11.63 on volume of 1,651,796 shares. Over the past year the S&P 500 is lower by -10.87% while VKTX has risen 213.54%. VKTX lost -$0.90 per share the over the last 12 months. Click Here to get the full Stock Report for Viking Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App